JNJ

Big Pharma Paying Healthy Dividends
Big Pharma Paying Healthy Dividends
Yahoo/IndieResearch
dividends
Big Pharma
Pfizer
JNJ
GSK
Eli Lilly
Roche
Merck
Flag link:
[video]No Shortage of Suitors for Genzyme
[video]No Shortage of Suitors for Genzyme
Yahoo/Morningstar
Genzyme
M&A
GSK
JNJ
Sanofi
Flag link:
Medtronic, Stryker, J&J Face New U.S. Rules for Medical Device Approvals
Medtronic, Stryker, J&J Face New U.S. Rules for Medical Device Approvals
FDA
Medtronic
Stryker
JNJ
Flag link:
Medtronic, Stryker, J&J Face New U.S. Rules for Medical Device Approvals
Medtronic, Stryker, J&J Face New U.S. Rules for Medical Device Approvals
Medtronic
JNJ
Stryker
Flag link:
Merck Plays Down J&J Arbitration but Risk Remains
Merck Plays Down J&J Arbitration but Risk Remains
Seeking Alpha
Merck
JNJ
Simponi
Remicade
Flag link:
Sanofi-Aventis Will Need to Raise Bid to Win Genzyme
Sanofi-Aventis Will Need to Raise Bid to Win Genzyme
WSJ Online
GSK
JNJ
Genzyme
M&A
Sanofi
Flag link:
Sanofi sends $69/share offer to Genzyme: sources
Sanofi sends $69/share offer to Genzyme: sources
Yahoo/Reuters
M&A
Sanofi
Genzyme
GSK
JNJ
Flag link:
More Genzyme Buyout Estimates Rolling In
More Genzyme Buyout Estimates Rolling In
Yahoo/IndieResearch
Genzyme
M&A
Sanofi
JNJ
GSK
Flag link:
Ky. to get $2 million in drug company settlement
Ky. to get $2 million in drug company settlement
Yahoo/AP
Kentucky
JNJ
Topamax
settlements
off-label
Flag link:
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Seeking Alpha
Genzyme
Sanofi
M&A
GSK
JNJ
Flag link:
Is Johnson & Johnson Really a Safety Stock?
Is Johnson & Johnson Really a Safety Stock?
Seeking Alpha
JNJ
GSK
Novartis
Sanofi
AstraZeneca
Flag link:
J&J's McNeil Problems Are Credit Negative
J&J's McNeil Problems Are Credit Negative
Seeking Alpha
JNJ
recalls
Flag link:
Sanofi Will Be Concerned About Overpaying for Genzyme
Sanofi Will Be Concerned About Overpaying for Genzyme
Seeking Alpha
Sanofi
Genzyme
JNJ
GSK
M&A
Flag link:
How Much Would You Pay for Genzyme?
How Much Would You Pay for Genzyme?
Motley Fool
Genzyme
M&A
Sanofi
GSK
JNJ
Flag link:
A.M. Vitals: Could Genzyme Attract Other Suitors?
A.M. Vitals: Could Genzyme Attract Other Suitors?
WSJ Online
Genzyme
M&A
GSK
Sanofi
JNJ
Flag link:
Biotech Stock Mailbag: Exact Sciences
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
EXACT Sciences
MannKind
Gilead Sciences
Somaxon
JNJ
Allos
Cell Therapeutics
Flag link:
Tibotec unveils results of experimental HIV drug
Tibotec unveils results of experimental HIV drug
Fierce Biotech
Tibotec
HIV
JNJ
rilpivirine
Flag link:
Why I Bought Call Options on Mylan
Why I Bought Call Options on Mylan
Seeking Alpha
Mylan
Eli Lilly
JNJ
Bristol-Myers Squibb
Teva Pharmaceuticals
generics
Flag link:
Johnson & Johnson Needs A Catalyst
Johnson & Johnson Needs A Catalyst
JNJ
Flag link:
15% Revenue Growth Is Good for Pfizer, but Not Gilead
15% Revenue Growth Is Good for Pfizer, but Not Gilead
Motley Fool
Pfizer
Gilead Sciences
earnings
JNJ
Bristol-Myers Squibb
Merck
Flag link:

Pages